Skip to main content
Equibles
TKNO logo

TKNO · Alpha Teknova, Inc. · Webcasts, Transcripts & Audio

Track TKNO — free

Use TKNO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TKNO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$8.99 +0.13 (+1.47%) At close · Oct 2
Russell 2000 member Rebalance outlook locked
Market Cap
$500.91M
Shares
53.69M
Volume · Oct 2 249.32K Avg daily vol (3M) 223.88K

Alpha Teknova, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Alpha Teknova, Inc. (TKNO), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲13.8% $10.69M −$22.47M '22 Q3 22-11-09 ▼21.9% $7.89M −$13.29M '22 Q4 23-03-15 ▼18.2% $9.12M −$8.82M '23 Q1 23-05-10 ▼1.4% $11.53M −$7.15M '23 Q2 23-08-10 ▼23.6% $8.17M −$10.15M '23 Q3 23-11-09 ▼0.3% $7.87M −$10.66M '23 Q4 24-03-11 ▲1.9% $9.29M −$8.10M '24 Q1 24-05-13 ▼16.6% $9.61M −$5.36M '24 Q2 24-07-09 ▲17.2% $9.58M −$7.57M '24 Q3 24-11-07 ▲17.8% $9.27M −$5.72M '24 Q4 25-03-04 ▲5.4% $9.79M −$4.64M '25 Q1 25-05-08 ▲7% $10.29M −$3.57M '25 Q2 25-08-07 ▲9.2% $10.45M −$4.29M '25 Q3 25-11-06 ▲7.8% $9.98M −$4.76M '25 Q4 26-02-26 ▲13.1% $11.08M −$4.55M '26 Q1 26-05-06 LATEST ▲18.5% $12.19M −$3.17M '26 Q2 26-08-05
Earnings call
FY26 · Q2
2026-08-05
Alpha Teknova, Inc. (TKNO) Q2 2026 Earnings Call Transcript
Confident tone Biotech funding environment Clinical pipeline and commercialization tailwinds BuildPet / BuildTech AI configurator launch
Revenue
$12.19M
▲ 18.5% YoY
Diluted EPS
$-0.06
Gross margin
40.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-06
Alpha Teknova, Inc. (TKNO) Q1 2026 Earnings Call Transcript
Positive tone Revenue growth and end market stabilization Clinical Solutions momentum Path to 2027 ~20% revenue growth
Revenue
$11.08M
▲ 13.1% YoY
Diluted EPS
$-0.08
Gross margin
34.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-03-19
Alpha Teknova, Inc. (TKNO) March 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-02-26
Alpha Teknova, Inc. (TKNO) Q4 2025 Earnings Call Transcript
Confident tone GMP clinical / therapy growth Cash usage and path to EBITDA positive Margin and operating leverage outlook
Revenue
$9.98M*
▲ 7.8% YoY
Gross margin
32.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Alpha Teknova, Inc. (TKNO) Q3 2025 Earnings Call Transcript
Positive tone Clinical Solutions / GMP pipeline Lab Essentials and catalog product growth Biopharma end-market weakness
Revenue
$10.45M
▲ 9.2% YoY
Diluted EPS
$-0.08
Gross margin
30.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Alpha Teknova, Inc. (TKNO) Q2 2025 Earnings Call Transcript
Confident tone Catalog products growth Custom clinical reagents Guidance and outlook
Revenue
$10.29M
▲ 7% YoY
Diluted EPS
$-0.07
Gross margin
38.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Alpha Teknova, Inc. (TKNO) Q1 2025 Earnings Call Transcript
Positive tone Custom products to biopharma (clinical) Collaboration / M&A (Pluristics) Custom products to life science tools and diagnostics
Revenue
$9.79M
▲ 5.4% YoY
Diluted EPS
$-0.09
Gross margin
30.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-04
Alpha Teknova, Inc. (TKNO) Q4 2024 Earnings Call
Revenue
$9.27M*
▲ 17.8% YoY
Gross margin
23.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Alpha Teknova, Inc. (TKNO) Q3 2024 Earnings Call Transcript
Positive tone Revenue Growth and Clinical Solutions Momentum Biopharma Market Environment Gross Margin and Inventory Charge
Revenue
$9.58M
▲ 17.2% YoY
Diluted EPS
$-0.15
Gross margin
0.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-09
Alpha Teknova, Inc. (TKNO) Q2 2024 Earnings Call Transcript
Positive tone Revenue performance and guidance New product launches (RUO+ and Express-Tek) Market environment and biotech funding
Revenue
$9.61M
▼ 16.6% YoY
Diluted EPS
$-0.13
Gross margin
29.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-13
Alpha Teknova, Inc. (TKNO) Q1 2024 Earnings Call Transcript
Positive tone Revenue and 2024 Guidance Gross Margin Leverage Capital Expenditures
Revenue
$9.29M
▲ 1.9% YoY
Diluted EPS
$-0.20
Gross margin
23.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-11
Alpha Teknova, Inc. (TKNO) Q4 2023 Earnings Call Transcript
Cautious tone Clinical Solutions / cell and gene therapy growth Lab Essentials SKU rationalization and customer count Gross margin compression
Revenue
$7.87M*
▼ 0.3% YoY
Gross margin
17.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-09
Alpha Teknova, Inc. (TKNO) Q3 2023 Earnings Call Transcript
Revenue
$8.17M
▼ 23.6% YoY
Diluted EPS
$-0.34
Gross margin
18.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-10
Alpha Teknova, Inc. (TKNO) Q2 2023 Earnings Call Transcript
Revenue
$11.53M
▼ 1.4% YoY
Diluted EPS
$-0.25
Gross margin
43.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
Alpha Teknova, Inc. (TKNO) Q1 2023 Earnings Call Transcript
Revenue
$9.12M
▼ 18.2% YoY
Diluted EPS
$-0.31
Gross margin
26.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-15
Alpha Teknova, Inc. (TKNO) Q4 2022 Earnings Call Transcript
Revenue
$7.89M*
▼ 21.9% YoY
Gross margin
26.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-09
Alpha Teknova, Inc. (TKNO) Q3 2022 Earnings Call Transcript
Revenue
$10.69M
▲ 13.8% YoY
Diluted EPS
$-0.80
Gross margin
44.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-10
Alpha Teknova, Inc. (TKNO) Q2 2022 Earnings Call Transcript
Revenue
$11.69M
▲ 40.6% YoY
Diluted EPS
$-0.22
Gross margin
44.9%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-11
Alpha Teknova, Inc. (TKNO) Q1 2022 Earnings Call Transcript
Revenue
$11.15M
▲ 22.8% YoY
Diluted EPS
$-0.20
Gross margin
48.0%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-15
Alpha Teknova, Inc. (TKNO) Q4 2021 Earnings Call Transcript
Revenue
$10.11M*
Gross margin
49.2%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-10
Alpha Teknova, Inc. (TKNO) Q3 2021 Earnings Call Transcript
Revenue
$9.39M
▲ 4.5% YoY
Diluted EPS
$-0.12
▼ 271.4% YoY
Gross margin
45.4%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-11
Alpha Teknova, Inc. (TKNO) Q2 2021 Earnings Call
Revenue
$8.31M
▲ 37.5% YoY
Diluted EPS
$-0.52
▼ 2700% YoY
Gross margin
40.3%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–22 of 22 webcasts
Key facts CIK 1850902 CUSIP 02080L102 13F (30d) 1 filings 1 filers Visit website Investor relations